NOVARTIS

NOVARTIS

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished... dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV; and collaboration with Artios Pharma Limited to create next generation DDR cancer therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Novartis_logo

Industry:
Multinational Pharmaceutical Company

Founded:
1996

Address:
Lichtstrasse 35, Basel, Switzerland Zipcode 4056

Country:
Switzerland

Phone:
41 61 324 1111

Company Size Range:
10001+
Current Employees:
44,054
Total Employees:
117,021

Market Cap:
197.94B
Total Revenue:
49.9B
Total Assets:
132.06B
Total Cash:
9.66B

Founders: Alexander Clavel · Johann Rudolf

Corporate leaders

Joerg Reinhardt, Ph.d._image

Joerg Reinhardt, Ph.d.
Chairman

Enrico Vanni, Ph.d._image

Enrico Vanni, Ph.d.
Vice Chairman

Charlotte Pamer-wieser, Ph…_image

Charlotte Pamer-wieser, Ph…
Corporate S…


Key Executives
Name Title Pay Year Born
Dr. Vasant Narasimhan Chief Exec. Officer 5,064,074$ 1976(44 years old)
Mr. Harry Kirsch Chief Financial Officer 2,665,003$ 1965(55 years old)
Mr. Steffen Lang Ph.D. Global Head of Technical Operations 2,011,228$ 1967(53 years old)
Dr. Klaus Moosmayer Ph.D. Chief Ethics, Risk & Compliance Officer 1,321,242$ 1968(52 years old)
Mr. Steven Baert Chief People & Organization Officer 2,181,614$ 1974(46 years old)
Dr. John Tsai Head of Global Drug Devel. & Chief Medical Officer 2,291,218$ 1967(53 years old)
Mr. Robert Weltevreden Head of Customer & Technology Solutions 1,560,270$ 1969(51 years old)
Ms. Susanne Schaffert Ph.D. Pres of Novartis Oncology 2,997,497$ 1967(53 years old)
Mr. Richard Saynor Chief Exec. Officer of Sandoz 3,780,624$ 1967(53 years old)
Dr. James E. Bradner Pres of Novartis Institutes for Biomedical Research 3,203,052$ 1972(48 years old)



Financial & Stock
Exchange NYSE. Currency in USD. Market state CLOSED
According to Novartis's financial reports the company's revenue in 2020 were 49.9B an increase( +2.08%) over the years 2019 revenue that were of 48.68B. In 2020 the company's total earnings were 8.07B while total earnings in 2019 were 11.73B(-27.27%).
Company's stock symbol is NVS. Lastest price : 88.02. Total volume :1.88M Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.novartis.com

  • Host name: 104.18.1.16
  • IP address: 104.18.1.16
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...
Loading ...


More informations about "Novartis" on Search Engine

Novartis.com Mar 30, 2021 · Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novartis.com Novartis Gene Therapies is dedicated to developing and commercializing gene …

Novartis.com Novartis Institutes for Biomed. Research Fabrikstrasse 2 Novartis Campus CH-4056 …

Novartis.com Novartis signs initial agreement to reserve capacity and implement the technology …

Novartis.com Novartis works with the patient community around the world to discover new ways to …

Novartis.com Novartis is honored to be one of the top 3 companies with the best corporate …

Novartis - Wikipedia

En.wikipedia.org Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), deferasirox (Exjade), and others.

Novartis agrees to make ingredients Roche's Actemra for

News.yahoo.com 2 days ago · Swiss drugmaker Novartis has signed a deal to make ingredients for Roche's Actemra treatment that is being repurposed for people with COVID-19, the company said on Thursday. The arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firms to help fight the pandemic.

Patient Assistance | Novartis United States of America

Novartis.us If you are a patient with commercial insurance and are finding it difficult to afford your medicines, the Novartis co-pay assistance program may be able to help. Eligible patients pay no more than USD 30 for a 30-day prescription (USD 1 per day) through retail or mail order for the vast majority of our branded and biosimilar products , including our cancer portfolio .

Products: Afinitor, Kisqali, Sandostatin, and more | Novartis

Hcp.novartis.com Novartis offers a breadth of medicines to treat and prevent severe diseases and/or medical conditions; from advanced kidney cancer to cataracts, and more. Products: Afinitor, Kisqali, Sandostatin, and more | …

Novartis Pharmaceuticals Corporation Company Information

Drugs.com 109 rows · Novartis Pharmaceuticals Corporation manufactures, markets and/or distributes more than …

Homepage | Novartis Foundation

Novartisfoundation.org The Novartis Foundation aims to improve the health of low-income populations by working with local authorities and partners to re-engineer health systems from being reactive to proactive, predictive and preventative. Our work starts with defining new and transformative approaches that can address the world’s most important population health ...

NVS Stock Price | Novartis AG ADR Stock Quote (U.S.: NYSE)

Marketwatch.com Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and...

The Culture And Leadership Code Of Novartis

Forbes.com Jan 20, 2021 · To learn more about how Novartis scales leadership development as a sales powerhouse, I spoke with Alison Pulte, associate director of leadership development for Novartis’ U. S.-based first- and ...

Novartis pays $150M to license Akcea-Ionis cardiac disease

Fiercebiotech.com Feb 25, 2019 · Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 million payout that Akcea Therapeutics will share with Ionis Pharmaceuticals. The decision sets...

Novartis (NVS) Collaborates with Roche for API of RA Drug

Nasdaq.com 1 day ago · This is the third manufacturing deal for Novartis, as last month, it announced an agreement to manufacture the mRNA and bulk drug product for CureVac’s CVAC COVID-19 …

Homepage | Novartis Biome

Biome.novartis.com The Novartis Biome is a network of innovation hubs, able to use this global platform to democratize access to tech innovation and expertise, and keep in step with the ever-evolving healthcare landscape.

Novartis: Clinical trials

Novartisclinicaltrials.com Novartis is committed to sharing with qualified external researchers, anonymized voluntary data and clinical study reports from our clinical trials for medicines in indications approved by regulators in the United State (US) and European Union (EU).

Novartis

Gnf.org Biotherapeutics & Biotechnology. GNF is a nimble organization that can rapidly move novel ideas from the lab to the clinic. The ultimate goal is to embrace high-risk, high reward science and disrupt how researchers conduct drug disco..

Home - Novartis FCU

Novartisfcu.org 124 South Ridgedale Avenue East Hanover, NJ 07936-3190. Phone: 973-947-1000 FAX: 973-947-1001. Routing Number: 221278556 NMLS#422379

Welcome - Novartis Reporting Home 2020

Reporting.novartis.com The Novartis in Society ESG Report details progress on environmental, social and governance topics and demonstrates the company’s commitment in global health and corporate responsibility.

Novartis Oncology for Health Care Professionals

Hcp.novartis.com You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.

Acting Manhattan U.S. Attorney Announces $678 Million

Justice.gov Jul 01, 2020 · NOVARTIS paid many high-prescribing doctors tens or hundreds of thousands of dollars in honoraria. In thousands of instances, NOVARTIS paid for the same group of doctors, often colleagues or friends, to have dinners together repeatedly. Doctors in these groups would sometimes rotate being the speaker and receiving the honorarium payment.

Novartis AG (NVS) Stock Price, News, Quote & History

Finance.yahoo.com The Novartis pact is the second major discovery deal for Artios after the company agreed in December to work with Merck KGaA (OTCMKTS: MKGAF) on small …

Novartis, Roche team up on COVID pneumonia drug

Medicalxpress.com 2 days ago · Novartis announced Thursday it will join forces with fellow Swiss pharmaceutical giant Roche to produce tocilizumab, a drug being tested for its …

Pharmaceuticals | Novartis Canada

Novartis.ca Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.

Financial Assistance | Novartis Oncology Patient Support

Patient.novartisoncology.com to patients. At Novartis Oncology, patients are our priority. That's why we go beyond the medicines we make to bring you the support and resources you need to help you during your journey. From financial assistance to online support, learn how we can make it as simple as possible for you to get connected to resources that can help.

Novartis Oncology Patient Support and Financial Assistance

Patient.novartisoncology.com Novartis Oncology Patient Support is designed to help meet the needs of patients and caregivers by making it easier to access Novartis Oncology medicine(s). Patient Assistance Now Oncology (PANO) representatives will guide you to patient support options that fit your needs.

Working at Novartis: 1,519 Reviews | Indeed.com

Indeed.com Novartis is a place where people feel empowered, respected and supported. Management is open minded, teams are dynamic and there is a wide choices for people to find their best fit.

Home [www.novitas-solutions.com]

Novitas-solutions.com Medicare JL. Contact Us: Join E-Mail List: Policy Search: Novitasphere : Providers in DC, DE, MD, NJ & PA

Novartis Corporation Corporate Integrity Agreement

Oig.hhs.gov “Novartis Affiliate” shall mean any entity that is owned or controlled, directly or indirectly, by Novartis Corporation and engages in Covered Functions other than Sandoz, Inc. and any of its direct or indirect wholly owned subsidiaries. Advanced Accelerator Applications USA, Inc. (AAA) is also included

Novartis Gene Therapies | Careers Center | Welcome

Careers-novartis-genetherapies.icims.com Since Novartis Gene Therapies (formerly AveXis) was acquired in 2018, we have been strategically aligning to move towards One Novartis. This integration is actively underway and roles for Gene Therapies can be found under both the Novartis Career page, as …

NVS - Novartis AG (ADR) Profile | Reuters

Reuters.com Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs ...

4. Novartis | FiercePharma

Fiercepharma.com Apr 20, 2020 · Novartis kept things busy in 2019 as it continued to focus on becoming a top medicines company. It spun off eye care medtech business Alcon, and at …

Novartis | LinkedIn

Linkedin.com Novartis | 2,705,508 followers on LinkedIn. Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital ...

Novartis and Microsoft announce collaboration to transform

News.microsoft.com Oct 01, 2019 · Novartis Data & Digital . Novartis is focusing itself as a leading medicines company powered by advanced therapies and data science. Going big on data and digital is a key strategic pillar that helps Novartis realize that ambition. Data science and digital technologies allow the company to reimagine how it innovates in R&D, engages with ...

Novartis - ServiceNow - Customer Story

Servicenow.com Novartis International AG, is a Swiss multinational, employing more than 125,000 people globally. One of the world’s largest pharmaceutical companies, with a vision to be a trusted leader in changing the practice of medicine, it commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.

Careers | Novartis India

Novartis.in Novartis strives to ensure we have every opportunity to drive our own learning and personal growth. BioCamp The Novartis Biotechnology Leadership Camp (BioCamp) is a biotechnology seminar for students. Well-being Novartis takes a holistic approach to supporting us to be our best selves every day and everywhere.

Novartis - Forbes

Forbes.com Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and ...

Novartis Portal for Healthcare Professionals| Novartis Portal

Portal.novartis.com Chat Live. We have representatives in real-time waiting to provide the information you need. Our hours of operation are Monday-Friday, 8:30 AM-5:00 PM ET, excluding major holidays.For immediate assistance, please call our Customer Interaction Center at: 1-888-644-2763. Chat should NOT be …

Novartis - NGCS

Ngcs.novartis.com Welcome to Novartis Grants Central Station Novartis Pharmaceuticals Corporation discovers and develops innovative products to treat diseases, ease suffering and enhance patient quality of life. Novartis is committed to the advancement of these goals through education, advocacy and outreach.

Enroll in the Novartis Oncology Universal Co-pay Program

Copay.novartis.com Novartis reserves the right to rescind, revoke, or amend the program and discontinue support at any time without notice. Patient Instructions: After enrollment in the program, present this card and your insurance card along with a valid prescription at any participating pharmacy or through mail order.

Novartis Data Exchange Hompage

Securemail.novartis.com The Novartis Data Exchange (NDX) service provides a web portal based utility that allows the secure exchange of large amounts of file based data. The data volume is limited to 30GB, whereas single files must not be larger than 2GB (see 'File size limitation' in the FAQ's).

NetBenefits Login - Novartis

Nb.fidelity.com If you have an account on Fidelity.com, use the same username and password.

Novartis, Roche to work together on one drug - MarketWatch

Marketwatch.com 2 days ago · Novartis said the agreement is to reserve capacity and implement a technology transfer for the production of the active pharmaceutical ingredient in Roche's Actemra/RoActemra, a rheumatoid ...